Autoantibodies to DEK oncoprotein in systemic lupus erythematosus (SLE). 2000

I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
Servicio de Inmunología, Hospital Universitario Virgen del Rocio, Servicio Andaluz de Salud, Sevilla, Spain.

Autoantibodies against the transcriptional DEK protein have been considered characteristic of the pauciarticular onset subtype of juvenile rheumatoid arthritis (JRA) associated with iridocyclitis in young girls. In this study we investigated the presence of anti-DEK autoantibodies in the sera of 288 patients with SLE using a recombinant DEK protein as autoantigenic target. Thirty sera (10.4%) were positive against DEK protein by immunoblotting. Patients with anti-DEK autoantibodies show a lower frequency of cutaneous manifestation, exhibit more frequently certain markers of a chronic inflammatory status like anaemia and positivity for C-reactive protein, as well as a higher frequency of anti-double-stranded DNA autoantibodies. In contrast to JRA patients positive for anti-DEK autoantibodies, no association with erosive arthritis nor iridocyclitis were found in SLE. In conclusion, our results show that 10.4% of SLE patients from our area show antibodies against DEK protein, although this feature did not clearly establish a clinical subset of the disease.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002868 Chromosomal Proteins, Non-Histone Nucleoproteins, which in contrast to HISTONES, are acid insoluble. They are involved in chromosomal functions; e.g. they bind selectively to DNA, stimulate transcription resulting in tissue-specific RNA synthesis and undergo specific changes in response to various hormones or phytomitogens. Non-Histone Chromosomal Proteins,Chromosomal Proteins, Non Histone,Chromosomal Proteins, Nonhistone,Non-Histone Chromosomal Phosphoproteins,Chromosomal Phosphoproteins, Non-Histone,Non Histone Chromosomal Phosphoproteins,Non Histone Chromosomal Proteins,Nonhistone Chromosomal Proteins,Proteins, Non-Histone Chromosomal
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000075223 Poly-ADP-Ribose Binding Proteins Proteins that contain POLY-ADP RIBOSE BINDING MOTIFS. They include HISTONES and other proteins that function in DNA REPAIR, replication, gene transcription, and APOPTOSIS. pADPr-Binding Proteins,Binding Proteins, Poly-ADP-Ribose,Poly ADP Ribose Binding Proteins,pADPr Binding Proteins
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody
D001323 Autoantibodies Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them. Autoantibody

Related Publications

I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
August 1998, Arthritis and rheumatism,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
January 1993, Nihon rinsho. Japanese journal of clinical medicine,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
December 1975, Die Medizinische Welt,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
November 2006, Ginekologia polska,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
January 2000, Arthritis and rheumatism,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
February 1998, Clinical and experimental immunology,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
June 1993, Minerva medica,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
November 2016, Nature reviews. Rheumatology,
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
February 1988, Ryumachi. [Rheumatism],
I Wichmann, and N Respaldiza, and J R Garcia-Lozano, and M Montes, and J Sanchez-Roman, and A Nuñez-Roldan
January 2000, Clinical rheumatology,
Copied contents to your clipboard!